Literature DB >> 22670176

Necrotic epithelial cells in proximal renal tubules of 2nd trimester fetuses: is this "acute tubular necrosis"?

Luiz Cesar Peres1, Chitra Sethuraman, Mudher Al-Adnani, Marta Cecilia Cohen.   

Abstract

PURPOSE: The aim of this study is to describe the occurrence of necrotic tubular cells in kidneys of non-macerated fetuses.
METHODS: Description of histology and immunostaining results using C9 immunostain of proximal tubular epithelium of kidneys from 30 consecutive non-macerated fetuses' autopsies.
RESULTS: the gestational age ranged from 13 to 22 weeks. The mean gestational age was 18.6 weeks; the cause of death was acute chorioamnionitis in 13 cases (43.3%), termination of pregnancy for fetal anomalies in 13 (43.3%) and other causes in 4 (13.3%). Histology of the kidneys revealed vacuolation of proximal tubule epithelial cells (100%), dilatation of tubules (93.4%) and tubular cell necrosis (53.4%). C9 immunostaining was positive in 24 cases (80%) and was seen in all gestational ages.
CONCLUSIONS: These results indicate that tubular cell necrosis is not an uncommon finding in the kidneys of 2(nd) trimester fetuses and may represent acute tubular necrosis (ATN). C9 is a helpful marker in confirming this diagnosis. Future studies may further explore this preliminary observation.

Entities:  

Keywords:  C9; Fetus; autopsy; hypoxic-ischemic lesion; kidney; tubular necrosis

Mesh:

Substances:

Year:  2012        PMID: 22670176      PMCID: PMC3365822     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  13 in total

1.  Human complement C7 and C9 in fetal and newborn sera.

Authors:  M Adinolfi; S E Beck
Journal:  Arch Dis Child       Date:  1975-07       Impact factor: 3.791

2.  Immunohistochemical detection of myocardial necrosis in stillbirth and neonatal death.

Authors:  E J Lazda; W H Batchelor; P M Cox
Journal:  Pediatr Dev Pathol       Date:  2000 Jan-Feb

3.  [Fetal shock syndrome].

Authors:  W Künzel
Journal:  Z Geburtshilfe Perinatol       Date:  1986 Sep-Oct

4.  Complement component 9 activation, consumption, and neuronal deposition in the post-hypoxic-ischemic central nervous system of human newborn infants.

Authors:  Seth J Schultz; Hany Aly; Bothina M Hasanen; Mohamed T Khashaba; Sheron C Lear; Robert W Bendon; Laura E Gordon; Pamela W Feldhoff; Herbert A Lassiter
Journal:  Neurosci Lett       Date:  2005-01-06       Impact factor: 3.046

Review 5.  Pathophysiologic features and prevention of human and experimental acute tubular necrosis.

Authors:  N Lameire; R Vanholder
Journal:  J Am Soc Nephrol       Date:  2001-02       Impact factor: 10.121

6.  Laminar necrosis of placental membranes: a histologic sign of uteroplacental hypoxia.

Authors:  Jerzy Stanek; Hikmat A Al-Ahmadie
Journal:  Pediatr Dev Pathol       Date:  2005-02-08

7.  Detection of myocardial infarction by immunohistological staining for C9 on formalin fixed, paraffin wax embedded sections.

Authors:  J P Doran; A J Howie; J N Townend; R S Bonser
Journal:  J Clin Pathol       Date:  1996-01       Impact factor: 3.411

Review 8.  Mifepristone: ten years later.

Authors:  Eric A Schaff
Journal:  Contraception       Date:  2010-01       Impact factor: 3.375

9.  Estimating the time of death in stillborn fetuses: I. Histologic evaluation of fetal organs; an autopsy study of 150 stillborns.

Authors:  D R Genest; M A Williams; M F Greene
Journal:  Obstet Gynecol       Date:  1992-10       Impact factor: 7.661

Review 10.  Acute kidney injury in children.

Authors:  Sharon Phillips Andreoli
Journal:  Pediatr Nephrol       Date:  2008-12-13       Impact factor: 3.714

View more
  1 in total

1.  Therapeutic Targeting of Aristolochic Acid Induced Uremic Toxin Retention, SMAD 2/3 and JNK/ERK Pathways in Tubulointerstitial Fibrosis: Nephroprotective Role of Propolis in Chronic Kidney Disease.

Authors:  Jia-Feng Chang; Chih-Yu Hsieh; Kuo-Cheng Lu; Yue-Wen Chen; Shih-Shin Liang; Chih-Cheng Lin; Chi-Feng Hung; Jian-Chiun Liou; Mai-Szu Wu
Journal:  Toxins (Basel)       Date:  2020-06-02       Impact factor: 4.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.